How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

SE

NASDAQ:SERA
Get a brief AI stock analysisSaves ~ 15 minutes of your time

SE

Sera Prognostics IncNASDAQ SERA Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is SERA undervalued compared to its fair value?

The fair value of SERA stock is hidden USD. Relative to the market price of 7.8 USD Sera Prognostics Inc is hidden.

Sera Prognostics, Inc. is a women’s health diagnostic company that is focused on utilizing its proteomics and bioinformatics platform to discover, develop and commercialize clinically impactful biomarker tests, with an i...[More about valuation]

Sera Prognostics Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.25 $B

Price:

7.8 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.251

FINANCIALS

Sera Prognostics financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0091 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0081 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

0.09 B
0.065 B

0.0005 B

Financial Position Analysis

Assets

0.09 B
Current Assets
0.054 B
Total non-current assets
0.036 B

Total current liabilities
0.025 B
Total non-current liabilities
0.0006 B

Cash Flow Statement

0.0042 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.005 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Sera Prognostics fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-46 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-177 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-36 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is SERA attractive for investment based on fundamental analysis?

SERA stock rating is hidden. Sera Prognostics is a hidden by Eyestock methodology.

Get SERA Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-16 802

Gross Margin:

20

CFO / Debt ratio:

hidden

Current ratio:

2.96

Debt / Equity ratio:

0.009

ROE:

-46

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

SERA analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for SERA to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Sera Prognostics Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Sera Prognostics Inc dividends

SERA dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About SERA stock

About the company Sera Prognostics Inc

Market cap $B

0.25

Dividend yield

Shares outstanding

31.016959 B

Sera Prognostics, Inc. is a women’s health diagnostic company that is focused on utilizing its proteomics and bioinformatics platform to discover, develop and commercialize clinically impactful biomarker tests, with an initial focus on improving pregnancy outcomes. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are accurate predictors of dynamic changes that occur during pregnancy. The Company's commercial product, the PreTRM test, is a blood-based biomarker test to accurately predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 19 or 20 of gestation. Its biomarker pregnancy pipeline includes preeclampsia, molecular time-to-birth, gestational diabetes mellitus (GDM), fetal growth restriction, stillbirth and postpartum depression.

SERA profile

  • Ticker

    SERA

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    15 July 2021

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    115

  • City

    Salt Lake City

  • Address

    2749 E. Parleys Way, Suite 200

  • Cusip

    81749D107